Venous disease is an umbrella term for conditions in which the veins, primarily in the legs, stop moving blood back toward the heart efficiently. It ranges from cosmetic spider veins to debilitating leg ulcers that cost billions of dollars a year to treat, and it affects a surprisingly large share of the adult population. The underlying problem is deceptively simple: gravity pulls blood downward, and when the structures meant to counteract that force weaken or fail, a cascade of inflammation and tissue damage follows. What makes venous disease worth understanding beyond the basics is how many different forms it takes, how often it goes unrecognized until it is advanced, and how much the treatment landscape has changed in the last two decades.
How Blood Gets Back Up Your Legs
Veins in the legs face a unique challenge. Unlike arteries, which benefit from the pumping force of the heart, veins rely on a combination of one-way valves and the squeezing action of the calf muscles to push blood upward against gravity. The calf muscle pump is the primary engine: every time you walk, flex your foot, or shift weight, your calf muscles compress the deep veins and propel blood toward the heart. This pump also generates a pressure difference between the thigh and lower leg that helps keep blood moving in the right direction.1PubMed Central. Calf pump activity influencing venous hemodynamics in the lower extremity
When this pump weakens, the consequences extend beyond sluggish circulation. A population-based study found that people with reduced calf pump function had roughly 70 percent higher odds of developing a deep-vein blood clot in the affected leg compared to those with normal pump function.2PubMed Central. Reduced calf muscle pump function is a risk factor for venous thromboembolism: a population-based cohort study That finding is striking because it links something as seemingly benign as weak calves to one of the more dangerous complications of venous disease.
What Goes Wrong Inside the Vein Wall
The damage in chronic venous disease does not just involve the valves. When blood pools in the legs because of valve failure or weak pumping, pressure inside the veins rises. That sustained high pressure triggers a molecular chain reaction. The vein wall becomes inflamed, white blood cells infiltrate, and enzymes called matrix metalloproteinases begin breaking down the structural proteins, especially collagen and elastin, that keep the vein wall firm.3PubMed Central. Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins These same enzymes can also relax the smooth muscle in the vein wall, causing the vein to dilate further.4PubMed Central. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease
The result is a vicious circle. Wider veins mean the valve leaflets can no longer meet in the middle, so blood refluxes back downward, which increases pressure further, which triggers more inflammation and more enzyme activity, which weakens the wall even more. Different sections of the same varicose vein can look completely different under a microscope: some regions are thin and stretched with heavy enzyme activity, while others are thickened with scar-like collagen deposits where the enzymes have been less active.5PubMed Central. Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease This patchwork remodeling is why varicose veins have that characteristic bulging, twisted appearance rather than being uniformly enlarged.
Who Gets Venous Disease and Why
One of the more interesting findings in recent years is the strength of the genetic component. A large genome-wide study of roughly half a million people identified 30 distinct genetic regions linked to varicose veins, with pathways involved in both vascular development and the biology of the skeleton and limbs.6PubMed Central. Clinical and Genetic Determinants of Varicose Veins: A Prospective, Community-Based Study of ~500,000 Individuals The skeletal connection is not as odd as it sounds: leg length, joint flexibility, and the angle of your ankle all affect how effectively the calf pump works, and those traits are themselves genetically influenced.
Beyond genetics, age is the single strongest risk factor. As people get older, coagulation factor levels rise, vein walls lose elasticity, valve function deteriorates, and the chance of prolonged immobility from illness or injury increases.7PubMed Central. Basic mechanisms and pathogenesis of venous thrombosis Other well-established contributors include obesity, prolonged standing or sitting, and previous blood clots.
Hormonal factors play a role as well. Research on women using oral contraceptives found that standard-dose formulations produced more significant leg heaviness, pain, and abnormal sensations like burning or prickling than lower-dose formulations. Functional symptoms often appeared years before visible varicose veins, suggesting that estrogen and progesterone accelerate venous disease in people who already have predisposing factors like family history, obesity, or occupations that require standing for long stretches. From an evolutionary perspective, some researchers have argued that the human venous system adapted well to bipedal walking but never fully adapted to prolonged motionless standing or sitting, two behaviors that are common in modern life but rare in our evolutionary past.8PubMed Central. Vicious Circle With Venous Hypertension, Irregular Flow, Pathological Venous Wall Remodeling, and Valve Destruction in Chronic Venous Disease: A Review
The Spectrum From Spider Veins to Leg Ulcers
Venous disease is classified using the CEAP system, which doctors use to describe the clinical severity of what they see. At the mild end are spider veins and reticular veins, the small blue-green lines visible through the skin. A step up are varicose veins, the ropy, raised vessels most people picture when they hear “vein problems.” Further along the spectrum come skin changes: swelling that does not fully resolve overnight, brownish discoloration around the ankles, eczema-like itching, and a hardened, woody texture of the skin and fat underneath called lipodermatosclerosis. At the severe end sit venous leg ulcers, open wounds that can take months or years to heal. CEAP is purely descriptive; it tells clinicians what is present but does not by itself predict how fast the disease will progress.9Vasa. Revision of the CEAP classification for chronic venous disorders: a consensus statement
The transition from skin changes to ulceration involves a specific inflammatory process. When venous pressure stays elevated, white blood cells become trapped in the tiny blood vessels of the skin, stick to the vessel walls, and release a barrage of inflammatory molecules including free radicals, enzymes, and signaling chemicals. This reaction feeds on itself, progressively remodeling the skin and subcutaneous tissue into the stiff, scarred state that is vulnerable to breakdown.10Annals of Vascular Surgery. Venous disease and inflammation Even reversing the elevated pressure does not immediately call those activated white blood cells back; they remain stuck to the vessel lining and continue releasing inflammatory signals.11PubMed. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease This helps explain why venous skin damage is so slow to recover even after treatment corrects the underlying reflux.
Deep Vein Thrombosis and Its Aftermath
While most conversation about venous disease centers on visible varicose veins, the deep venous system has its own problems. Deep vein thrombosis, a blood clot in one of the large veins inside the leg, is dangerous in the short term because clot fragments can travel to the lungs and cause a pulmonary embolism. But the long-term fallout is often underappreciated. After a deep vein clot, somewhere between one in five and one in two patients develop post-thrombotic syndrome, a form of chronic venous insufficiency caused by the clot scarring the vein and damaging its valves.12PubMed Central. The post-thrombotic syndrome
Severity depends heavily on where the original clot sat. A long-term follow-up study tracked patients for fourteen years after their first clot. Among those whose clot was limited to veins below the knee, about 19 percent developed moderate-to-severe post-thrombotic symptoms. For clots extending up into the iliac and femoral veins of the upper thigh and pelvis, that figure rose to roughly 37 percent.13PubMed. Very long-term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis The principal risk factors for this complication are extensive clots, repeat clots in the same leg, persistent symptoms a month after the initial event, obesity, and older age.14PubMed Central. The post-thrombotic syndrome Deep venous valve failure from post-thrombotic damage can ultimately lead to the same painful, difficult-to-treat leg ulcers seen in chronic venous insufficiency from other causes.15PubMed Central. SAVVE US pivotal study of patients with severe chronic insufficiency due to deep valvular venous reflux: One-year results after VenoValve implantation
How Venous Disease Is Diagnosed
Duplex ultrasound is the standard tool for evaluating venous disease. It combines a conventional image of the veins with Doppler flow measurements, allowing a technician to see the anatomy and watch blood move in real time. Incompetent valves show up as backward flow lasting longer than half a second in the superficial veins or longer than one second in the deep veins when the examiner squeezes or releases the calf or asks the patient to bear down. The test is painless, takes about 30 to 45 minutes per leg, and can map exactly which veins are refluxing and which are clear, information that is critical for planning any intervention.
Doctors pair the ultrasound findings with the CEAP classification to get a full picture. CEAP describes what is visible (clinical signs, cause, anatomic location, and underlying mechanism), while the ultrasound fills in the hemodynamic detail beneath the surface. In some cases, CT or MRI venography is added when the deep veins or pelvic veins need a closer look, particularly if a structural problem like compression of a vein is suspected.
Compression and Exercise as First-Line Treatment
Graduated compression stockings remain the cornerstone of conservative management. They work by applying the most pressure at the ankle and progressively less pressure up the leg, which helps squeeze blood upward and reduces the diameter of superficial veins. Even light compression increases the speed of blood flow through the popliteal vein behind the knee and shrinks vein diameter, with mild-to-moderate pressure levels boosting peak flow velocity by roughly a quarter.16PubMed. Effects of graduated compression stockings with different pressure profiles on lower-limb venous structures and haemodynamics In healthy people standing for prolonged periods, compression stockings at ankle pressures of around 10 to 15 mmHg reduced leg swelling and symptoms compared to standing without them.
However, compression alone does not fix the underlying problem. In patients with post-thrombotic syndrome, low-strength stockings did not produce the same significant hemodynamic improvements seen in patients with straightforward varicose veins.17PubMed. Haemodynamic Performance of Low Strength Below Knee Graduated Elastic Compression Stockings in Health, Venous Disease, and Lymphoedema This is one reason post-thrombotic patients often need more aggressive treatment beyond stockings.
Structured exercise programs targeting the calf muscles have shown real benefit. A randomized trial found that after six months of a supervised calf exercise program, patients with chronic venous insufficiency saw their calf pump function return to the normal range, with statistically significant improvements in both how much blood the pump ejected and how much was left behind.18PubMed. Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomized trial Other studies have confirmed that exercise improves pump performance and muscle strength, though it does not reverse the valve reflux itself.19PubMed. Effect of exercise on calf muscle pump function in patients with chronic venous disease A systematic review noted that patients with milder disease also gained improvements in quality of life from exercise, while those with advanced disease saw physical improvements but not the same quality-of-life bump.20PubMed Central. The impact of exercise training on calf pump function, muscle strength, ankle range of motion, and health-related quality of life in patients with chronic venous insufficiency at different stages of severity: a systematic review
Procedures for Varicose Veins
The treatment of varicose veins has shifted dramatically from open surgery toward minimally invasive options that can be done in an office with local anesthesia. The main techniques target the incompetent saphenous trunk, the large superficial vein running up the inside of the leg that is the root source of reflux in most cases.
Traditional surgery involved tying off the saphenous vein at the groin and physically pulling it out through small incisions, a procedure called ligation and stripping. It works, but recovery takes longer: patients in comparative trials took a median of about four days off work and reported higher pain scores afterward than those treated with newer methods.21British Journal of Surgery. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins
Endovenous thermal ablation, using either laser energy or radiofrequency, has largely replaced stripping. Both methods involve threading a thin catheter into the vein and heating it shut from the inside. In a head-to-head trial, radiofrequency ablation produced less postoperative pain than laser ablation and surgical stripping, and patients returned to daily activities sooner.22Cardiovascular Surgery and Interventions. Radiofrequency ablation versus high ligation and stripping for the treatment of symptomatic great saphenous vein insufficiency: Short-term patient-reported outcomes At one year, both laser and radiofrequency had low rates of the treated vein reopening, around 5 percent, compared to about 16 percent for foam sclerotherapy.23British Journal of Surgery. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins
The newest entrant is cyanoacrylate glue, sold under the brand name VenaSeal. Instead of heat, this method uses a medical adhesive injected inside the vein to seal it shut. Because no heat is involved, there is no need for the multiple anesthetic injections along the vein that thermal methods require. A large retrospective study of over 800 treated veins reported a closure rate above 97 percent at the third follow-up, with no cases of clinically significant deep vein thrombosis related to the glue.24PubMed. Real-World Safety and Efficiency of Treating Symptomatic Varicose Veins with Endovenous Closure of Great, Small, and Anterior Accessory Veins Using Cyanoacrylate Glue (VenaSealâ„¢): A Single-surgeon Multicenter Retrospective Study Compared to foam sclerotherapy, glue treatment has shown lower recurrence rates and higher patient satisfaction.25International Journal of Health Sciences. Comparison of foam sclerotherapy and cyanoacrylate glue for preventing the recurrence of varicose veins However, one thing stripping still has going for it: a meta-analysis found that surgical stripping was over four times as likely to remain technically successful at two years compared to laser ablation in some trial comparisons, suggesting the long-term durability picture is still being sorted out.26PubMed Central. Endovenous laser ablation versus conventional surgery (ligation and stripping) for primary great saphenous varicose vein: a systematic review and meta-analysis
Medications That Target Vein Wall Biology
A class of drugs called venoactive compounds is widely used in Europe and parts of Asia, though less familiar to patients in the United States. These drugs work on several fronts: they improve vein tone, reduce leakiness of the capillary lining, dampen white blood cell adhesion to the vein wall, and promote lymphatic drainage to reduce swelling.27PubMed Central. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy
Not all venoactive compounds have the same strength of evidence behind them. A recent review found that micronized purified flavonoid fraction and a combination of ruscus extract with hesperidin and vitamin C had the strongest evidence for relieving pain, heaviness, and cramps. For venous leg ulcers specifically, micronized purified flavonoid fraction, sulodexide, and pentoxifylline were the most effective additions to standard wound care, each supported by high-quality evidence.28PubMed Central. The role of venoactive compounds in the treatment of chronic venous disease These drugs are considered adjunctive treatments, meaning they are added on top of compression and other measures rather than used alone.
May-Thurner Syndrome and Structural Compression
Not all venous disease starts in the veins themselves. In May-Thurner syndrome, the left common iliac vein in the pelvis is compressed by the right common iliac artery crossing over it. This anatomical quirk can restrict blood flow from the left leg, leading to swelling, pain, and a heightened risk of deep vein thrombosis on the left side.29PubMed Central. Endovascular Stenting for May-Thurner Syndrome: A Case Report It often goes undetected until a seemingly unprovoked left-leg clot prompts further imaging.
The treatment is typically endovascular stenting, where a metal stent is placed inside the compressed vein to hold it open. Technical success rates are high, above 90 percent in reported series, and most patients experience complete symptom relief.30PubMed Central. Endovascular Treatment of Iliac Vein Compression (May-Thurner) Syndrome: Angioplasty and Stenting with or without Manual Aspiration Thrombectomy and Catheter-Directed Thrombolysis Long-term stent patency is generally good, though certain factors raise the risk of the stent clotting off: having chronic post-thrombotic scarring in the vein and placing the stent below a key anatomical junction both substantially increased the odds of stent failure in one cohort study.31PubMed Central. Risk factors for stent occlusion after catheter-directed thrombolysis and iliac vein stenting in the treatment of May-Thurner syndrome with iliofemoral deep vein thrombosis: a retrospective cohort study
The Financial Weight of Venous Disease
Venous disease is not just a quality-of-life issue; it is an economic one. An analysis estimated that the annual direct medical costs for patients with venous leg ulcers related to deep venous reflux totaled roughly $10.7 billion across seven countries, with the United States alone accounting for nearly $5 billion of that figure. On a per-patient basis, that translates to about $5,500 per year in direct medical spending.32PubMed Central. An estimate of the economic burden of venous leg ulcers associated with deep venous disease And those numbers reflect only patients being managed conservatively with wound care; they do not include the costs of surgery, procedures, lost work, or disability.
Much of this cost is driven by how long venous ulcers take to heal. An ulcer that stays open for months requires regular clinic visits, specialized dressings, home nursing, and sometimes hospitalization for infection. When you consider that roughly 5 to 10 percent of all post-thrombotic patients eventually develop ulcers, and that the aging population is growing in every developed country, the economic trajectory is not hard to predict.33PubMed Central. The post-thrombotic syndrome Early intervention at the varicose vein or chronic swelling stage, before ulcers form, is far cheaper than treating the ulcers themselves. Yet many patients and even some primary care doctors treat early venous symptoms as purely cosmetic and delay referral to a specialist until the skin is already damaged.
Thrombosis Risk Factors Beyond Veins
When people think about blood clots, they often focus on the veins. But the risk factors for venous thrombosis extend well beyond vein health. Cancer is a major driver: tumors produce tissue factor that activates the clotting cascade and shed tiny particles into the bloodstream that promote coagulation.34PubMed Central. Basic mechanisms and pathogenesis of venous thrombosis On the genetic side, about 5 percent of people of European descent carry a variant called factor V Leiden, which makes one of the clotting proteins resistant to the body’s normal off-switch. Having this variant alone modestly raises clot risk, but combining it with something like oral contraceptive use multiplies the risk dramatically. The interplay between inherited clotting tendencies and environmental triggers is central to understanding why some people get clots and others, with seemingly identical lifestyles, do not.